Despite lingering concerns about increased susceptibility to heart problems when taking Avandia, a Type 2 diabetes medication, the majority of a Federal Drug Administration advisory panel suggested that the drug have looser restrictions. It will now be up to FDA Commissioner Margaret Hamburg to make a decision.
NOT FOR REPRINT
FDA panel urges looser restrictions on diabetes drug Avandia
By
Staff Writer
June 07, 2013 at 11:56 AM
Share & Print
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
